Oncology CME

Credits: 1.50 CNE
Medical Learning Institute, Inc.
Clinical Advances in Pancreatic Cancer: The Oncology Nurse as a Leader and Advocate for Patients in a Changing Therapeutic Landscape
Gayle Jameson, MSN, ACNP-BC, AOCN
22 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
An Oncology Nurse MasterClass on Oral Therapy in B-Cell Malignancies: Insights on Evidence, Practical Strategies, and the Nurse-Patient Partnership
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
22 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Oncology Nurses on the Advances and Challenges
Kimberly Halla, MSN, FNP-C
21 May, 2019
Credits: 1.50 CNE / CE
Medical Learning Institute, Inc.
Taking Aim at B-Cell Malignancies With BTK Inhibitors: Oncology Nurse Perspectives and Insights on Clinical Care
Mollie Moran, APRN-CNP, AOCNP
16 May, 2019
Credits: 1.50 MOC / CME / CNE
Medical Learning Institute, Inc.
The Present and Future of Immunotherapy as a Key Component of the Treatment Arsenal for Locally Advanced & Earlier Stages of Lung Cancer
Leora Horn, MD, MSc, FRCPC
9 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine
BTK Inhibition as an Anti-Cancer Strategy: Exploring a Model for Modern Targeted Therapy in Hematologic Malignancies and Beyond
John Byrd, MD
6 May, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Rethinking Care in Hepatocellular Carcinoma Amid Expanding Treatment Options: An Interdisciplinary Discussion
Richard S. Finn, MD / Laura M. Kulik, MD
6 May, 2019
Credits: 1.50 MOC / CME
Medical Learning Institute, Inc.
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Implications for Pathologists at the Forefront of the Emerging Precision Immuno-Oncology Era
Robert Anders, MD, PhD
1 May, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Oncology Nurse Insights Into New Agent Classes and Research in B-Cell Lymphoma: Practical Issues and Evidence for the Front-Lines of Care
Amy Goodrich, NP
30 April, 2019
Credits: 1.50 MOC / CME / CNE
Medical Learning Institute, Inc.
New Frontiers in Precision Immuno-Oncology: Leveraging Biomarkers to Refine and Expand the Use of Cancer Immunotherapies and Combinations
Justin Gainor, MD
26 April, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Progress and Promise With Immunotherapy in Resectable Melanoma: Exploring New Evidence and Practical Issues With Checkpoint Inhibitors as Adjuvant Therapy
Jason J. Luke, MD, FACP / Jennifer Wargo, MD, MMSc
25 April, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Refining Current Practice and Exploring New Frontiers in EGFR-Mutant NSCLC: Evolving Science, New Standards of Care, and Implications for Multidisciplinary Management
Benjamin Levy, MD
17 April, 2019
Credits: 1.50 MOC / CME / CNE
Medical Learning Institute, Inc.
Addressing Unmet Needs in Earlier Stages of NSCLC With Immunotherapy: Cutting-Edge Research, Clinical Applications, and Practical Challenges
Scott Antonia, MD, PhD
15 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings
Sagar Lonial, MD, FACP
10 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment
Mitchell Cairo, MD
3 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation
Tanya Siddiqi, MD / Shannon L. Maude, MD, PhD
2 April, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
Alexander Perl, MD / James M. Foran, MD, FRCPC
29 March, 2019
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Rheumatology, Immunology, and Immuno-Oncology Intersect: Navigating the Complexities of Immune Checkpoint Inhibition, Autoimmunity, and Immune-Related Adverse Events
Leonard Calabrese, DO
29 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook
Madan Jagasia, MBBS, MS, MMHC
28 March, 2019
Credits: 1.00 MOC / CME / CNE
Medical Learning Institute, Inc.
Expanding Options and Difficult Choices in the Initial Treatment of Advanced NSCLC: How to Personalize Treatment Decisions in the Era of Immuno-Oncology and Combinations
Mark Socinski, MD
27 March, 2019
Credits: 1.50 CME
Purdue University College of Pharmacy
Unraveling the Complexities of Prostate Cancer Management: Focus on Therapeutic Decisions for Early-Stage Disease and the Implications for Later-Stage Disease
Robert Dreicer, MD, MS, MACP, FASCO
26 March, 2019
Credits: 1.00 CME
The Medical College of Wisconsin
Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
Roy Chemaly, MD, MPH, FIDSA, FACP
26 March, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making Effective Therapeutic Choices for Advanced RCC in an Evolving Treatment Landscape: Personal Insights From the Patient CaseBook
David McDermott, MD
20 March, 2019
Credits: 0.50 CME
University of Nebraska Medical Center
Exploring Clinical Decisions in the New Era of Myeloma Management: The Impact of Novel Platforms and Agent Classes Across the Spectrum of Care
Luciano Costa, MD, PhD
13 March, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED
Evan Lipson, MD
22 February, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes
Richard Finn, MD
15 February, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Building Innovative Treatment Options for Patients With B-Cell Malignancies: Practical Insights on Clinical Evidence and Integration Strategies
Nathan Fowler, MD
15 February, 2019
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
Anna Farago, MD, PhD
7 February, 2019
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and Updated Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
6 February, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progress in Developing Novel Treatment Options for PTCL: Expert Views on Integrating Innovative Therapeutics Into Care
Younes Anas, MD
29 January, 2019

Pages